Ignite Creation Date:
2025-12-24 @ 11:51 AM
Ignite Modification Date:
2025-12-28 @ 4:30 AM
Study NCT ID:
NCT02750761
Status:
COMPLETED
Last Update Posted:
2019-12-20
First Post:
2016-04-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-02
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-21
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-01
First Submit QC Date:
None
Study First Post Date:
2016-04-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-12-02
Results First Submit QC Date:
None
Results First Post Date:
2019-12-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-02
Last Update Post Date:
2019-12-20
Last Update Post Date Type:
ACTUAL